Literature DB >> 11888094

Evaluation of serum creatine kinase in ectopic pregnancy with reference to tubal status and histopathology.

Osman H Develioglu1, Cenk Askalli, Gurkan Uncu, Billur Samli, Omer Daragenli.   

Abstract

OBJECTIVE: To study the value of creatine kinase in ectopic pregnancy with reference to tubal histopathology.
DESIGN: Prospective controlled study.
SETTING: Academic tertiary-care institution. POPULATION: Thirty-two women with ectopic pregnancy and 20 controls with intrauterine pregnancies.
METHODS: Creatine kinase and beta-hCG levels were measured on admission. Ectopic pregnancies were removed at surgery and examined histologically. MAIN OUTCOME MEASURES: Tubal localisation and integrity of ectopic pregnancies as judged at surgery and later histologically, and placental growth patterns in unruptured ectopic pregnancies classified as intraluminal, extraluminal or mixed as determined histologically.
RESULTS: Creatine kinase levels were higher in isthmic than ampullary ectopic pregnancies (P = 0.011), and higher in ruptured than in unruptured cases (P = 0.003) and normal pregnancies (P < 0.0001). A creatine kinase value >120iu/L was 65% sensitive and 87% specific in discriminating ruptured from unruptured ectopic pregnancies. Creatine kinase levels were above this cutoff in two of five unruptured ampullary ectopic pregnancies with invasive trophoblastic growth, yet in none of nine cases with intraluminally confined placentation (P = 0.04). Creatine kinase was positively correlated with gestational age in ruptured (P = 0.007), but not in unruptured ectopic pregnancies or normal pregnancies.
CONCLUSIONS: Serum creatine kinase may help in discriminating ruptured from unruptured ectopic pregnancies, while it is not useful for the primary diagnosis of ectopic pregnancy. An increase in creatine kinase levels accompanying muscular damage in ectopic pregnancy probably antedates tubal rupture, and may be related to trophoblastic growth patterns.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888094     DOI: 10.1111/j.1471-0528.2002.00243.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  7 in total

Review 1.  The need for serum biomarker development for diagnosing and excluding tubal ectopic pregnancy.

Authors:  Andrew W Horne; W Colin Duncan; Hilary Od Critchley
Journal:  Acta Obstet Gynecol Scand       Date:  2010-03       Impact factor: 3.636

2.  Endometrial cysteine-rich secretory protein 3 is inhibited by human chorionic gonadotrophin, and is increased in the decidua of tubal ectopic pregnancy.

Authors:  A W Horne; W C Duncan; A E King; S Burgess; P C Lourenco; P Cornes; P Ghazal; A R Williams; L Udby; H O D Critchley
Journal:  Mol Hum Reprod       Date:  2009-03-12       Impact factor: 4.025

3.  The Role of Plasma Creatine Phosphokinase (CPK) Level in Prediction of Response to Methotrexate for Ectopic Pregnancy.

Authors:  Fatemeh Davari-Tanha; Mohadese Ghazi; Mona Mohseni; Farahnaz Ahmadi
Journal:  J Family Reprod Health       Date:  2016-06

4.  Creatine phosphokinase, a new marker in diagnosis of tubal ectopic pregnancy; A Systematic Review.

Authors:  Maryam Ghorbani; Afsaneh Keramat; Farideh Mohsenzadeh Ledari
Journal:  Arch Acad Emerg Med       Date:  2020-01-11

5.  Assessment of the diagnostic capability of serum creatine phosphokinase and its isoenzyme in ectopic pregnancy.

Authors:  Attaollah Ghahiri; Aidin Moshreffar; Aida Najafian; Mojdeh Ghasemi; Hatav Ghasemi Tehrani
Journal:  Int J Fertil Steril       Date:  2012-12-17

6.  Evaluation of Plasma Creatine Phosphokinase (CPK) Level Following a Single Injection of Methotrexate as a Predicator of Treatment Success in Ectopic Pregnancy.

Authors:  Leila Safdarian; Marzieh Aghahosseini; Ashraf Alleyassin; Mina Kohbodi
Journal:  J Family Reprod Health       Date:  2013-12

7.  Evaluation of serum creatine phosphokinase in diagnosis of tubal ectopic pregnancy compared with intrauterine pregnancy and threatened abortion.

Authors:  Maryam Asgharnia; Roya Faraji; Fariba Mirblouk; Zahra Atrkar Roshan; Ayda Parvizi
Journal:  Iran J Reprod Med       Date:  2012-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.